Alterations of colonic cholinergic and tachykininergic motility in a rat model of Parkinson's Disease

Keyphrases

• Motility 100%
• 6-Hydroxydopamine-lesioned Rats 100%
• Rat Model of Parkinson's Disease 100%
• Parkinson's Disease 50%
• Substance P 50%
• Electrical Stimulation 50%
• Carbachol 50%
• Atropine 50%
• Nigrostriatal System 50%
• L-732,138 50%
• Exogenous Substances 50%
• Parkinson Patients 25%
• Acetylcholine 25%
• Motor Function 25%
• Dopaminergic Neurons 25%
• After Surgery 25%
• Muscarinic Receptors 25%
• Colon 25%
• Arginine 25%
• Enteric Nervous System 25%
• Organ Bath 25%
• Contractile Response 25%
• 6-hydroxydopamine (6-OHDA) 25%
• Longitudinal muscle 25%
• Methyl Ester 25%
• Comparisons with a Control 25%
• Cholinergic Contraction 25%
• Guanethidine 25%
• Neurotoxic Lesion 25%
• Motor Dysfunction 25%
• Motor Alterations 25%
• Nigrostriatal Pathway 25%
• Stereotaxic Injection 25%
• Neurokinin-1 Receptor Antagonist 25%
• Medial Forebrain Bundle 25%
• Tachykinin 25%
• Dopaminergic Neurodegeneration 25%
• Nigrostriatal Degeneration 25%
• Cholinergic Transmission 25%
• Evoked Contractions 25%
• Gastrointestinal 25%
• Muscle Preparation 25%
• Neurotransmitter Pathways 25%
• Experimental Parkinson's Disease 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Rat Model 100%
• Cholinergic Receptor Stimulating Agent 100%
• Parkinson's Disease 100%
• Dopamine Receptor Stimulating Agent 50%
• Carbachol 50%
• Substance P 50%
• Muscarinic Receptor 25%
• Neurotransmitter 25%
• Motor Dysfunction 25%
• Guanethidine 25%
• Tachykinin 25%
• Striatonigral Degeneration 25%
• Experimental Parkinsonism 25%
• Acetylcholine 25%
• Receptor Antagonist 25%
• Arginine 25%
• Oxidopamine 25%